| ²é¿´: 811 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
janic670Òø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÒºÏàÉ«Æ×È·ÈÏ-½øÑù²ÐÁôÏîÄ¿µÄÏÞ¶È·Òë
|
||
|
¸÷λ³æÓÑÃÇ£¬ÓÐûÓÐ×ö¹ýÒºÏàÉ«Æ×È·ÈÏ-½øÑù²ÐÁôÏîÄ¿µÄ£¿Õâ¸ö½øÑù²ÐÁôµÄÏÞ¶ÈÖ¸±êÖеÄ2%ºÍ0.2%·Ö±ðÊÇÄĸöºÍÄĸö¶Ô±ÈµÃ³öµÄ£¿¾ÍÊÇÏÂÃæÕâ¾ä»°Ôõô·Ò룿 Limits: Carry-over: The percentage of the peak area corresponding to caffeine in the blank injection 2 does not exceed 2 % the peak area of the caffeine peak in the chromatogram obtained with reference solution (b) injected after the blank injection 2, this corresponds to 0.2 %. |
» ²ÂÄãϲ»¶
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ5È˻ظ´
302·Ö 085601Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ8È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ10È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
318Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´

pewpewpew
Òø³æ (³õÈëÎÄ̳)
- ·ÒëEPI: 20
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 409.1
- Ìû×Ó: 45
- ÔÚÏß: 57.1Сʱ
- ³æºÅ: 21455310
- ×¢²á: 2020-03-13
- רҵ: ÓлúºÏ³É
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
janic670: ½ð±Ò+5, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ѧϰÁË£¬Ð»Ð» 2022-09-22 14:11:48
janic670: ½ð±Ò+5, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ѧϰÁË£¬Ð»Ð» 2022-09-22 14:11:48
|
ÎÒ²ÂÕâÊÇEDQMµÄPA/PH/OMCL (11) 04 R6£¿ µÚ¶þ¸ö¿Õ°×ÑùÀïµÄ¿§·ÈÒòÉ«Æ×·åÃæ»ý²»³¬¹ýµÚ¶þ¸ö¿Õ°×Ñùºó½øµÄ¿§·ÈÒò¶ÔÕÕÆ·ÈÜÒº£¨b£©¿§·ÈÒò·åÃæ»ýµÄ2% ·åÃæ»ýÕ¼±ÈµÄ2%Ï൱ÓÚ0.2%µÄ½øÑùÆ÷²ÐÁô¡¾injector carry-over¡¿£¨ÕâÀï0.2%ÊÇEDQM¸øµÄinjector carry-overÔÚÒ»°ãÇé¿öϵĿɽÓÊÜ·¶Î§ÉÏÏÞ¡¾±í1ÓÐд¡¿£© |
2Â¥2022-09-19 15:24:07
janic670
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 273.3
- Ìû×Ó: 71
- ÔÚÏß: 89Сʱ
- ³æºÅ: 949953
- ×¢²á: 2010-01-28
- רҵ: É«Æ×·ÖÎö

3Â¥2022-09-22 14:10:16














»Ø¸´´ËÂ¥
120